- Ticker
- ACHL
- Price
- 0.84
- Stock movement down
- -0.04 (-4.55%)
- Company name
- Achilles Therapeutics PLC ADR
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 34.39M
- Ent value
- -120.77M
- Price/Sales
- -
- Price/Book
- 0.17
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -73.42%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2023-03-22
The following slide deck was published by Achilles Therapeutics plc in conjunction with this event.
March 15, 2023
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
March 7, 2023
iO Charts is a Seeking Alpha partner
DIVIDENDS
ACHL does not pay dividends or no data was received
I believe that recent selling in ACHL is due to tax loss sellers needing to recognize capital loss before the end of the year. See why you should Buy.
December 18, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 22, 2022
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 0.17 |
| EV to Sales | - |
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 8, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
August 9, 2022
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 40.94M |
| EPS (TTM) | -1.66 |
| FCF per share (TTM) | -0.88 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | -74.01M |
| Net income (TTM) | -65.35M |
| EPS (TTM) | -1.66 |
| EPS (1y forward) | -1.85 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 179.89M |
| Net receivables | 10.71M |
| Total current assets | 198.69M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 227.35M |
| Accounts payable | 7.52M |
| Short/Current long term debt | 8.99M |
| Total current liabilities | 19.06M |
| Total liabilities | 24.73M |
| Shareholder's equity | 202.62M |
| Net tangible assets | 202.62M |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -57.68M |
| Capital expenditures (TTM) | 5.46M |
| Free cash flow (TTM) | -34.43M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -32.25% |
| Return on Assets | -28.74% |
| Return on Invested Capital | -31.62% |
| Cash Return on Invested Capital | -16.66% |
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
July 21, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
May 10, 2022
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.88 |
| Daily high | 0.93 |
| Daily low | 0.83 |
| Daily Volume | 391K |
| All-time high | 17.86 |
| 1y analyst estimate | 12.40 |
| Beta | - |
| EPS (TTM) | -1.66 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 8 May 2023 |
Downside potential
Loading...
Downside potential data
| ACHL | S&P500 | |
| Current price drop from All-time high | -95.30% | -17.92% |
| Highest price drop | -95.58% | -56.47% |
| Date of highest drop | 22 Dec 2022 | 9 Mar 2009 |
| Avg drop from high | -73.10% | -11.51% |
| Avg time to new high | 249 days | 13 days |
| Max time to new high | 495 days | 1805 days |
The following slide deck was published by Achilles Therapeutics plc in conjunction with this event.
April 29, 2022
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
March 1, 2022
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
34.39M
Marketcap category
Small-cap
Description
Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. It is also developing products for use in the treatment of head and neck squamous cell carcinoma, renal cell carcinoma, triple negative breast cancer, and bladder cancer. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. The company was founded in 2016 and is headquartered in London, the United Kingdom.
Employees
242
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
January 13, 2022
iO Charts is a Seeking Alpha partner
Achilles Therapeutics plc (NASDAQ:NASDAQ:ACHL) SITC & Corporate Update Call November 12, 2021 8:30 AM ETCompany ParticipantsLee Stern - VP, IR & External CommunicationsIraj Ali -...
November 13, 2021
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 10, 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
November 9, 2021
iO Charts is a Seeking Alpha partner
COMPANY NEWS
All newsPress releases
- Demonstrated early proof-of-concept for cNeT therapy in heavily pre-treated advanced NSCLC patients - - Exhibited power of translational science platform by correlating anti-tumor activity of cNeT w...
March 7, 2023
Here is how Achilles Therapeutics PLC Sponsored ADR (ACHL) and Geron (GERN) have performed compared to their sector so far this year.
February 2, 2023
Here is how Anika Therapeutics (ANIK) and Achilles Therapeutics PLC Sponsored ADR (ACHL) have performed compared to their sector so far this year.
January 17, 2023
LONDON, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing AI-powered precision T cell therapies to treat solid tumors, t...
December 20, 2022
- Early proof-of-concept data support durable clinical benefit including confirmed partial response and stable disease in heavily pre-treated patients with advanced NSCLC - - Safety and tolerability p...
December 6, 2022
- Durable partial response (PR) and stable disease (SD) achieved in heavily pre-treated non-small cell lung cancer (NSCLC) patients dosed with cNeT monotherapy - - Updated interim Phase I/II results s...
November 30, 2022
- US patent is for an immunotherapy targeting clonal neoantigens identified by the Achilles Clonality Engine (ACE), including vaccine, antibody, and autologous T cell therapy approaches -LONDON, Nov. ...
November 22, 2022
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
November 13, 2022
- Interim update from the ongoing Phase I/IIa trials in advanced NSCLC (CHIRON) and melanoma (THETIS) to be presented at the ESMO Immuno-Oncology Annual Congress 2022 - - Strong cash balance of $179.9...
November 8, 2022
Achilles Therapeutics PLC Sponsored ADR (ACHL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the ...
November 1, 2022
Next page
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
October 22, 2021
iO Charts is a Seeking Alpha partner
Get the latest news and real-time alerts from Achilles Therapeutics plc (ACHL) stock at Seeking Alpha.
August 25, 2021
iO Charts is a Seeking Alpha partner